Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

RPTXRPTX
Showing 7 of 9 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in REPARE THERAPEUTICS INC

As of its Q4 2025 13F, Stifel held 10,000 shares of RPTX (Repare Therapeutics), worth $26,000. Stifel's 13F filings listed RPTX from Q1 2024 to Q4 2025, 8 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$177,848

Total Shares Change

-51,700

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$2.65
0
2025-Q4
Decreased
10,000
-87.1%
$26,0000.0%$2.58
0
2025-Q3
Decreased
77,600
-3.7%
$136,5760.0%$1.74
0
2025-Q2
Unchanged
80,600
0.0%
$112,0340.0%$1.39
0
2025-Q1
Decreased
80,600
-9.9%
$79,4690.0%$1.05
0
2024-Q4
Increased
89,500
+73.1%
$117,2450.0%$1.25
33
2024-Q3
Increased
51,700
+36.4%
$177,8480.0%$3.44
30

Other major holders of RPTX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used